Role Of Lipid Profile Parameters As Predictor Of Type 2 Diabetes Risk In Bhiwadi, Rajasthan
Main Article Content
Abstract
Type 2 diabetes mellitus (T2DM) and obesity are prevalent metabolic disorders in the Indian population, often linked to lifestyle changes leading to metabolic alterations. Elevated levels of circulating saccharides contribute to various metabolic disturbances, including T2DM and associated complications such as renal and retinal dysfunction. This study aimed to identify individuals at risk of T2DM through lipid profiling in Bhiwadi, Rajasthan. A total of 800 participants were enrolled, and parameters including lipid profiling levels (HDL, Cholesterol) were assessed. Among the participants, 400 males and 400 females exhibited lipid profiles indicative of T2DM risk. These findings underscore the significance of lipid profiling in identifying individuals at risk of T2DM and obesity-related complications. Lifestyle modifications and targeted interventions are crucial to mitigate the growing burden of these metabolic disorders, particularly in regions like Bhiwadi, Rajasthan, India.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Zimmet, P., Alberti, K. G., & Magliano, D. J. (2014). Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nature Reviews Endocrinology, 10(9), 616-622.
American Diabetes Association. "Diagnosis and classification of diabetes mellitus." Diabetes care 33.Supplement_1 (2010): S62-S69.
Bommer, C., Heesemann, E., Sagalova, V., Manne-Goehler, J., Atun, R., Bärnighausen, T., & Vollmer, S. (2018). The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. The Lancet Diabetes & Endocrinology, 6(6), 423-430.
Petersen, Max C., Daniel F. Vatner, and Gerald I. Shulman. "Regulation of hepatic glucose metabolism in health and disease." Nature reviews endocrinology 13.10 (2017): 572-587.
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018). IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice, 138, 271-281.
Balaji, R., Revathi Duraisamy, and M. P. Kumar. "Complications of diabetes mellitus: A review." Drug Invention Today 12.1 (2019).
MacIsaac, Richard J., Elif I. Ekinci, and George Jerums. "Markers of and risk factors for the development and progression of diabetic kidney disease." American journal of kidney diseases 63.2 (2014): S39-S62.
Mohan, Viswanathan, Siddharth Shah, and Banshi Saboo. "Current glycemic status and diabetes related complications among type 2 diabetes patients in India: data from the A1chieve study." The Journal of the Association of Physicians of India 61.1 Suppl (2013): 12-5.
Sugandh, F. N. U., et al. "Advances in the management of diabetes mellitus: a focus on personalized medicine." Cureus 15.8 (2023).
Fernandes, Rosa, et al. "Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy." Biochimica Et Biophysica Acta (BBA)-Molecular Basis of Disease 1865.7 (2019): 1876-1897.
White-Williams, Connie, et al. "Addressing social determinants of health in the care of patients with heart failure: a scientific statement from the American Heart Association." Circulation 141.22 (2020): e841-e863.
American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15-S33.
Emerging Risk Factors Collaboration, Sarwar N, Gao P, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215-22.
International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels, Belgium: International Diabetes Federation, 2019.
Molitch ME, DeFronzo RA, Franz MJ, et al. Nephropathy in diabetes. Diabetes Care. 2004;27 Suppl 1:S79-83.